Insurers move to waive cost-sharing for COVID-19 office visits

Some commercial payers are moving to cover cost-sharing and out-of-pocket costs for physician office visits related to COVID-19 screening, according to Forbes contributor Bruce Japsen.

Advertisement

On March 13, Cigna said it will “waive customers’ out-of-pocket costs for COVID-19 testing-related visits with in-network providers, whether at a doctor’s office, urgent care clinic, emergency room or via telehealth.” The change is effective through May 31. Other insurers have moved to waive cost-sharing for diagnostic testing for COVID-19 and have expanded telehealth access.

Policy changes vary from insurer to insurer. Health plans are encouraging their members to visit company websites, especially if they have coverage through their employer, according to Mr. Japsen.

More articles on healthcare payers:
UnitedHealth split causes Moody’s to change U.S. Anesthesia Partners outlook to negative
BCBS of Texas to reimburse out-of-network ER claims, pay $10M fine
BCBS of North Carolina wins $9.4B contract to manage state health plan

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.